Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

Topical eye β-blockers might cause hair loss, which usually gets better after stopping the medication.

Natural herbal compounds might treat certain medical conditions by reducing DHT levels, but more research is needed to confirm their effectiveness and safety.

New genes linked to ichthyosis were found, but there's still no cure; treatment options are improving.

A woman's total hair loss was linked to a Borrelia infection and was reversed with appropriate treatment.

A woman with a drug allergy to anakinra was successfully desensitized, allowing her to continue treatment without allergic reactions.

The top research priorities for congenital ichthyosis include long-term side effects of oral retinoids, best topical treatments, and treatments for itch and hair loss.

Various treatments exist for alopecia areata, but none are completely satisfactory; choice depends on age, disease extent, and preference.

Hair ages due to various factors and treatments like minoxidil and finasteride can help, but more research and better public awareness are needed.

The analysis aims to identify the most effective and safest treatments for alopecia areata.

Alopecia Areata is an autoimmune hair loss condition, with various treatments showing mixed effectiveness and no guaranteed cure.

The combined stem cell secretome in the skin care product effectively reduces inflammation and promotes tissue regeneration.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

Drug repositioning offers hope for new, affordable treatments for a genetic skin disorder called ARCI.

17β-estradiol may help hair growth by increasing cannabinoid receptor type 1.

The document explains various skin conditions and their treatments.

Alopecia Areata is an unpredictable autoimmune hair loss condition with limited and variable treatment effectiveness.

Women's hair gets thinner and grayer as they age, with treatments available for hair loss and graying.

Telogen effluvium is a common hair loss condition where many hairs enter the resting phase, often not noticeable until significant loss occurs, and treatment focuses on the underlying cause.

Lupus can cause different skin problems, and treatments like quitting smoking and using certain creams or medicines can help.

New patents include innovations in skin and hair care, disease treatment, plant stress tolerance, and protein purification.

Topical immunotherapy with DPCP is most effective for certain alopecia areata types, with success linked to age and disease duration, and influenced by a gene polymorphism.

AA–TF#15 significantly promotes hair regrowth and could be an effective treatment for androgenic alopecia.

PCOS is a complex condition with major health impacts, needing more research for better diagnosis and treatment.

Myo-inositol may be more effective than metformin for inducing ovulation in women with PCOS.

Scientists successfully made a human growth factor in a plant, which could help with hair growth and bone development.

The method allows for 3D tracking of hair follicle stem cells and shows they can regenerate hair for up to 180 days.

Continuous use of finasteride and minoxidil is effective for treating androgenetic alopecia.

Encapsulating hair loss drugs in cyclodextrins improves their solubility and reduces scalp irritation.

The document concludes that inherited epidermolysis bullosa is a challenging genetic condition requiring multidisciplinary care and new treatments.